November 1, 2017—The Centers for Medicare & Medicaid Services late today published a final Outpatient Prospective Payment System (OPPS) regulation that cuts Medicare Part B drug reimbursement to hospitals in the 340B drug discount program for separately payable drugs by nearly 30 percent, from average sales price (ASP) plus 6 percent to ASP minus 22.5 percent. The reduction … [Read more...]
Senators to HHS: Start Enforcing 340B Manufacturer Penalties Rule
October 31, 2017—Thirteen U.S. Senators have asked the Department of Health and Human Services to stop delaying enforcement of a 340B drug discount program final rule to police drug manufacturer overcharging. “HHS has conducted several rounds of public comment and had more than seven years to consider” the 340B ceiling price and manufacturer civil monetary penalties final … [Read more...]
Hospitals Will Have to Make Painful Cuts if CMS Slashes Drug Payments
October 26, 2017—Hospitals have begun the agonizing process of deciding which vital patient services to scale back or switch off should the Centers for Medicare & Medicaid Services (CMS) follow through with plans to slash Medicare drug reimbursement to 340B hospitals starting Jan. 1. Cancer care and help for patients addicted to opioids could be on the chopping block, … [Read more...]
340B Hospitals to CMS: Drug Reimbursement Cut Will Harm Patients
October 19, 2017 – A group of more than 1,300 hospitals serving low-income and rural communities is urging the Centers for Medicare & Medicaid Services (CMS) to withdraw its proposal to cut Medicare reimbursement for outpatient prescription drugs. Earlier this year, CMS issued a proposed rule that would cut Medicare Part B drug payments to hospitals participating in the … [Read more...]
House E&C Oversight Subcommittee 340B Hearing Recap
October 11, 2017—The House Energy & Commerce oversight subcommittee held its second hearing on the 340B program this morning, focusing on how covered entities track and use their savings to improve patient care. Three 340B hospitals and health systems testified – Mission Health (N.C.), The Johns Hopkins Hospital (Md.), and Northside Hospital (Ga.). The committee also heard … [Read more...]
Co-Founder of GOP Doctor’s Caucus Urges CMS To Withdraw Reimbursement Cut
October 11, 2017—The Centers for Medicare & Medicaid Services should “stand down and rescind its deleterious proposal” to slash what Medicare pays 340B hospitals for many of the most expensive medicines in use today, a co-founder of the U.S. House GOP Doctors Caucus says. In a recent commentary in the Capitol Hill newspaper The Hill, former Rep. Phil Gingrey (R-Ga.) … [Read more...]
House 340B Hearing Set for Oct. 11
October 5, 2017—The House Energy & Commerce oversight subcommittee is holding a second hearing on the 340B drug discount program on Oct. 11. The subcommittee will hear testimony from executives at health center networks in North and South Carolina, health systems in Maryland and Georgia, and a Wisconsin HIV clinic. Four of the five providers got letters from the … [Read more...]